Acupath Labs

Acupath is a provider of sub-specialized anatomic pathology services focused on the following specialties; Urology, Gastroenterology, Dermatology, Women’s Health, Otolaryngology, Podiatry, and Hematology / Oncology. Acupath offers an extensive test menu on both a global and TC/PC basis, processes well over 150,000 specimens annually, and is one of the leading providers of cutting edge FISH testing for the detection of bladder cancer (UroVysion™), prostate cancer (PTEN ERG), breast cancer (PathVysion™), melanoma, and esophageal cancer (Barrett’s esophagus FISH). The company will launch PCR tests in late 2019, with the initial focus on Urology (urinary tract infections) and Podiatry (nail and wound).